1FHC - Header Asymmetric Unit

HEADER C-TERMINAL DOMAINS OF FACTOR H 10-MAR-99 1FHC

TITLE C3D AND HEPARIN BINDING COMPLEMENT FACTOR H DOMAINS SCR19-20

COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN (COMPLEMENT FACTOR H); COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: SCR DOMAINS 19-20; COMPND 5 SYNONYM: CCP19-20, SCR19-20, SUSHI19-20

SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN

KEYWDS THEORETICAL MOLECULAR MODEL, COMPLEMENT, HUMAN, FACTOR H, KEYWDS 2 HEPARIN, SIALIC ACID, C3D, C3B

EXPDTA THEORETICAL MODEL

AUTHOR T.S.JOKIRANTA,J.HELLWAGE,M.A.FRIESE,T.U.WOLK,E.KAMPEN, AUTHOR 2 P.F.ZIPFEL,S.MERI

REVDAT 1 18-MAR-03 1FHC 0

JRNL AUTH J.HELLWAGE,T.S.JOKIRANTA,M.A.FRIESE,T.U.WOLK, JRNL AUTH 2 E.KAMPEN,P.F.ZIPFEL,S.MERI JRNL TITL COMPLEMENT C3B/C3D AND CELL SURFACE POLYANIONS ARE JRNL TITL 2 RECOGNIZED BY OVERLAPPING BINDING SITES ON THE JRNL TITL 3 MOST CARBOXY-TERMINAL DOMAIN OF COMPLEMENT FACTOR H JRNL REF J.IMMUNOL. V. 169 6935 2002 JRNL REFN ASTM JOIMA3 US ISSN 0022-1767

REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH B.NAGAR,R.G.JONES,R.J.DIEFENBACH,D.E.ISENMAN, REMARK 1 AUTH 2 J.M.RINI REMARK 1 TITL X-RAY CRYSTAL STRUCTURE OF C3D: A C3 FRAGMENT AND REMARK 1 TITL 2 LIGAND FOR COMPLEMENT RECEPTOR 2 REMARK 1 REF SCIENCE V. 280 1277 1998 REMARK 1 REFN ASTM SCIEAS US ISSN 0036-8075 REMARK 1 REFERENCE 2 REMARK 1 AUTH P.N.BARLOW,A.STEINKASSERER,D.G.NORMAN,B.KIEFFER, REMARK 1 AUTH 2 A.P.WILES,R.B.SIM,I.D.CAMPBELL REMARK 1 TITL SOLUTION STRUCTURE OF A PAIR OF COMPLEMENT MODULES REMARK 1 TITL 2 BY NUCLEAR MAGNETIC RESONANCE REMARK 1 REF J.MOL.BIOL. V. 232 268 1993 REMARK 1 REFN ASTM JMOBAK UK ISSN 0022-2836

REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE.

REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : NULL REMARK 3 AUTHORS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL

REMARK 4 REMARK 4 1FHC COMPLIES WITH FORMAT V. 3.0, 1-DEC-2006 REMARK 4 REMARK 4 THIS FILE IS A TEST VERSION. REMARK 4 REMARK 4 THIS IS THE REMEDIATED VERSION OF THIS PDB ENTRY. REMARK 4 REMEDIATED DATA FILE REVISION 3.100 (2007-05-01)

REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-MAR-1999. REMARK 100 THE RCSB ID CODE IS RCSB000615.

REMARK 220 REMARK 220 EXPERIMENTAL DETAILS REMARK 220 EXPERIMENT TYPE : THEORETICAL MODELLING REMARK 220 REMARK 220 REMARK: NULL

REMARK 225 REMARK 225 THEORETICAL MODEL REMARK 225 THE COORDINATES IN THIS ENTRY REPRESENT A MODEL STRUCTURE. REMARK 225 PROTEIN DATA BANK CONVENTIONS REQUIRE THAT CRYST1 AND REMARK 225 SCALE RECORDS BE INCLUDED, BUT THE VALUES ON THESE REMARK 225 RECORDS ARE MEANINGLESS.

REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A1116 -57.09 62.53 REMARK 500 SER A1126 166.05 69.78 REMARK 500 MET A1174 -88.67 53.18 REMARK 500 CYS A1201 -119.16 37.53 REMARK 500 LYS A1222 -63.73 76.73 REMARK 500 GLU A1224 155.53 63.68 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ASP A 1119 ILE A 1120 -148.74 REMARK 500 PHE A 1199 VAL A 1200 -146.75 REMARK 500 LYS A 1230 ARG A 1231 -121.15

DBREF 1FHC A 1105 1231 UNP P08603 CFAH_HUMAN 1105 1231

SEQRES 1 A 127 SER THR GLY LYS CYS GLY PRO PRO PRO PRO ILE ASP ASN SEQRES 2 A 127 GLY ASP ILE THR SER PHE PRO LEU SER VAL TYR ALA PRO SEQRES 3 A 127 ALA SER SER VAL GLU TYR GLN CYS GLN ASN LEU TYR GLN SEQRES 4 A 127 LEU GLU GLY ASN LYS ARG ILE THR CYS ARG ASN GLY GLN SEQRES 5 A 127 TRP SER GLU PRO PRO LYS CYS LEU HIS PRO CYS VAL ILE SEQRES 6 A 127 SER ARG GLU ILE MET GLU ASN TYR ASN ILE ALA LEU ARG SEQRES 7 A 127 TRP THR ALA LYS GLN LYS LEU TYR SER ARG THR GLY GLU SEQRES 8 A 127 SER VAL GLU PHE VAL CYS LYS ARG GLY TYR ARG LEU SER SEQRES 9 A 127 SER ARG SER HIS THR LEU ARG THR THR CYS TRP ASP GLY SEQRES 10 A 127 LYS LEU GLU TYR PRO THR CYS ALA LYS ARG

HELIX 1 1 GLU A 1145 ASN A 1147 5 3

SHEET 1 A 3 SER A1132 GLU A1135 0 SHEET 2 A 3 ARG A1149 ARG A1153 -1 N CYS A1152 O SER A1132 SHEET 3 A 3 GLN A1156 GLU A1159 -1 N GLU A1159 O THR A1151

SSBOND 1 CYS A 1109 CYS A 1152 SSBOND 2 CYS A 1138 CYS A 1163 SSBOND 3 CYS A 1167 CYS A 1218 SSBOND 4 CYS A 1201 CYS A 1228

CISPEP 1 SER A 1122 PHE A 1123 0 -10.53 CISPEP 2 SER A 1196 VAL A 1197 0 -14.34

CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1

ORIGX1 1.000000 0.000000 0.000000 0.00000

ORIGX2 0.000000 1.000000 0.000000 0.00000

ORIGX3 0.000000 0.000000 1.000000 0.00000

SCALE1 1.000000 0.000000 0.000000 0.00000

SCALE2 0.000000 1.000000 0.000000 0.00000

SCALE3 0.000000 0.000000 1.000000 0.00000